KMT2A and acute lymphoblastic leukemia: To summarize, the presence of MLL-AF4 in B-ALL likely downregulates miR-142-3p to prevent miR-142-3p suppression of MLL-AF4, downstream induction of apoptosis, and inhibition of tumor growth.